Glycovax Pharma
PrivateLast Round
Grant
Oct 8, 2025
Total Funding Raised
$2.98M
Company Overview
Glycovax Pharma is a biopharmaceutical company that develops innovative carbohydrate-based vaccines to address needs in oncology and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Glycovax Pharma Comps
Public and private peers based on sector, stage, and business model.
Glycovax Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 8, 2025 | ||||
| Grant | Oct 1, 2020 |
Key People
Founding team and executive leadership
Glycovax Pharma Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 8, 2025
$334K grant round completed.
- Oct 1, 2020
Secured $3M in grant funding.
Glycovax Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Glycovax Pharma's valuation, stock price, and market status.
